Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) lost more than 58 percent of their value Monday morning after the company reported disappointing results from its phase 2 STAR 1 clinical trial Continue reading “What Zynerba’s Flop Means For CBD Therapies And GW Pharmaceuticals”
Marijuana legalization advocates are planning to introduce a scaled-back version of their legislation that would legalize the drug next year but put the brakes on immediate plans for retail stores.
While the previous version of the bill called for legalizing the drug immediately, the new proposal calls for taking that step in July 2018 when recreational pot shops are slated to open in Massachusetts. In the interim, a six-person Cannabis Advisory Board would be established to study how the state should go about creating a recreational marijuana market. Continue reading “Rhode Island Legislatures to Introduce Plan for Marijuana Legalization in 2018”
John Oliver returned on Sunday after a brief hiatus with a detailed story about America’s most counter-productive and antiquated marijuana laws.
In addition to detailing how the U.S. tax code screws marijuana businesses that operate legally within their states, Oliver showed how federal regulations put individuals who were complying with state laws at risk. Continue reading “John Oliver Headlines Show With Marijuana Segment”
The Question 1 recount is over. And Wednesday, the Maine secretary of state certified the election results. Question 1, which legalizes the possession, cultivation and sale of recreational marijuana, will soon become law.
For now, many employers seem to be sticking with their drug testing and personal conduct policies, even in states where recreational marijuana use is now permitted. Others are keeping a close eye on the still evolving legal, regulatory and political environment. Continue reading “Five things for employees to know in states with marijuana laws”